Edwyn logo

Edwyn

Find Companies
Find Companies
Dashboard
Find Companies...

Footer

EdwynEdwyn

Conduct a Professional Comparative analysis in seconds. Empowering your financial decisions with data-driven insights.

Subscribe to our newsletter

Company

  • About
  • Contact us
  • Register

Legal

  • Privacy
  • Terms

Guides

  • What is Enterprise Value?
  • How much is my company worth?

© 2025 Edwyn, LLC. All rights reserved.

Edwyn logo

Edwyn

Enterprise Value
EV Calculator
Help
What is Enterprise Value?
    Log in
    Log in
    Tesla, Inc.
    Apple Inc.
    NVIDIA
    Walmart
    Microsoft
    No valuations found.
    Log in to save
    Edwyn logo

    Edwyn

    Tesla, Inc.
    Apple Inc.
    NVIDIA
    Walmart
    Microsoft
    No valuations found.
    Elevance Health, Inc. (ELV)
    Income
    Balance Sheet
    Market Cap
    $78B
    Latest price
    $340.69
    -1.13%
    Dollar Amounts
    USD (Millions)
    Metric20202021202220232024
    Revenue$121,867$138,639$156,595$171,340$177,011
    Gross Profit$112,914$127,744$143,560$154,047$157,261
    Operating Income$6,360$7,489$8,452$8,499$7,862
    Net Income$4,572$6,104$6,025$5,987$5,980
    Showing latest financials
    Data in millions of USD
    Doing some research...

    Commentary on Elevance Health, Inc. Performance

    Over the five-year period, Elevance Health’s revenue has shown steady growth, rising from approximately $121.9 billion in 2020 to $177.0 billion in 2024. The company’s gross profit has followed a similar upward trajectory, increasing from about $112.9 billion to $157.3 billion. This consistent improvement in top-line performance indicates an ability to grow its overall business amidst the competitive healthcare landscape. The revenue growth rates, however, appear to moderate over time. For instance, while the jump between 2020 and 2021 was more pronounced, the increase from 2023 to 2024 was relatively modest at just over 3%, suggesting a possible stabilization in market conditions or a maturing growth phase. In contrast, operating income and net income reveal a more nuanced picture. Operating income rose steadily through 2022, peaking at around $8.5 billion, but then declined modestly to about $7.9 billion in 2024. Net income improved significantly from 2020 to 2021, increasing from $4.6 billion to $6.1 billion, but then has remained largely flat, fluctuating slightly around the $6.0 billion mark thereafter. No dramatic year-over-year swings exceeding a 20% change were observed, which implies operational adjustments and market responses were incremental rather than radical. Overall, Elevance Health appears to be financially sound, maintaining steady revenue and profitability growth with modest fluctuations in operating efficiency—reflecting a stable business model within a tightly regulated and competitive healthcare industry.

    This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.